APG Asset Management US’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-41,897
Closed -$1.99M 74
2025
Q3
$1.99M Hold
41,897
0.01% 107
2025
Q2
$1.99M Hold
41,897
0.01% 101
2025
Q1
$2.49M Hold
41,897
0.02% 96
2024
Q4
$2.37M Buy
41,897
+12,546
+43% +$701K 0.02% 94
2024
Q3
$1.55M Sell
29,351
-105,405
-78% -$4.94M 0.01% 107
2024
Q2
$5.57M Sell
134,756
-3,314
-2% -$148K 0.03% 137
2024
Q1
$7.32M Sell
138,070
-51,204
-27% -$2.61M 0.04% 133
2023
Q4
$9.71M Buy
+189,274
New +$9.94M 0.06% 108

Other funds holding BMY

APG Asset Management US's BMY Position: Q4 2025 in Review

APG Asset Management US sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 41,897 shares — an estimated $1.99M sold.

APG Asset Management US first reported a position in BMY in Q4 2023 and held it in 8 quarters. The position peaked at $9.71M in Q4 2023. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • APG Asset Management US reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 41,897 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.99M.
  • APG Asset Management US first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Bristol-Myers Squibb position peaked at $9.71M in Q4 2023.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.